RU2002103867A - Aminobenzophenones as inhibitors of IL-1 β and TNF-α - Google Patents
Aminobenzophenones as inhibitors of IL-1 β and TNF-αInfo
- Publication number
- RU2002103867A RU2002103867A RU2002103867/04A RU2002103867A RU2002103867A RU 2002103867 A RU2002103867 A RU 2002103867A RU 2002103867/04 A RU2002103867/04 A RU 2002103867/04A RU 2002103867 A RU2002103867 A RU 2002103867A RU 2002103867 A RU2002103867 A RU 2002103867A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- group
- chloro
- phenyl
- bromo
- Prior art date
Links
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical class NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 title 1
- 102000003777 Interleukin-1 beta Human genes 0.000 title 1
- 108090000193 Interleukin-1 beta Proteins 0.000 title 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 title 1
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 20
- 125000001424 substituent group Chemical group 0.000 claims 13
- -1 hydroxy, mercapto Chemical group 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 6
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N Indometacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 3
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- 239000000460 chlorine Chemical group 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 239000011737 fluorine Substances 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical group 0.000 claims 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 150000003839 salts Chemical group 0.000 claims 3
- 239000011780 sodium chloride Chemical group 0.000 claims 3
- OQANPHBRHBJGNZ-BKUYFWCQSA-N (3Z)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid Chemical compound C1=CC(=O)C(C(=O)O)=C\C1=N/NC1=CC=C(S(=O)(=O)NC=2N=CC=CC=2)C=C1 OQANPHBRHBJGNZ-BKUYFWCQSA-N 0.000 claims 2
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 claims 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical class N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 claims 2
- 206010000496 Acne Diseases 0.000 claims 2
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 claims 2
- 206010002556 Ankylosing spondylitis Diseases 0.000 claims 2
- 229940006211 Anticholinergic mydriatics and cycloplegics Drugs 0.000 claims 2
- 229940065524 Anticholinergics inhalants for obstructive airway diseases Drugs 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 206010003246 Arthritis Diseases 0.000 claims 2
- 208000006673 Asthma Diseases 0.000 claims 2
- 206010011401 Crohn's disease Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 229940067594 Flufenamate Drugs 0.000 claims 2
- 229940065521 Glucocorticoid inhalants for obstructive airway disease Drugs 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 229960000905 Indomethacin Drugs 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- VVNCNSJFMMFHPL-VKHMYHEASA-N Penicillamine Chemical compound CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 claims 2
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 2
- 206010040070 Septic shock Diseases 0.000 claims 2
- 229940037128 Systemic Glucocorticoids Drugs 0.000 claims 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N Trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims 2
- 206010046851 Uveitis Diseases 0.000 claims 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- 239000000464 adrenergic agent Substances 0.000 claims 2
- 230000003042 antagnostic Effects 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 230000001078 anti-cholinergic Effects 0.000 claims 2
- 230000001387 anti-histamine Effects 0.000 claims 2
- 239000000739 antihistaminic agent Substances 0.000 claims 2
- 201000001320 atherosclerosis Diseases 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 239000000812 cholinergic antagonist Substances 0.000 claims 2
- 230000001684 chronic Effects 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- LPEPZBJOKDYZAD-UHFFFAOYSA-M flufenamate Chemical compound [O-]C(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-M 0.000 claims 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical group [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 2
- 239000003862 glucocorticoid Substances 0.000 claims 2
- 201000005569 gout Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000000968 intestinal Effects 0.000 claims 2
- 229960002009 naproxen Drugs 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229960001639 penicillamine Drugs 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000002062 proliferating Effects 0.000 claims 2
- 201000004681 psoriasis Diseases 0.000 claims 2
- 150000003873 salicylate salts Chemical class 0.000 claims 2
- 230000036303 septic shock Effects 0.000 claims 2
- 235000019166 vitamin D Nutrition 0.000 claims 2
- 239000011710 vitamin D Substances 0.000 claims 2
- 229940107161 Cholesterol Drugs 0.000 claims 1
- 229920000742 Cotton Polymers 0.000 claims 1
- 108010003541 Platelet Activating Factor Proteins 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- 208000006641 Skin Disease Diseases 0.000 claims 1
- 229960001940 Sulfasalazine Drugs 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000010586 diagram Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 200000000002 platelet activation Diseases 0.000 claims 1
- 230000001681 protective Effects 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- 150000003751 zinc Chemical class 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14416999P | 1999-07-16 | 1999-07-16 | |
US60/144,169 | 1999-07-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002103867A true RU2002103867A (en) | 2003-09-20 |
RU2238933C2 RU2238933C2 (en) | 2004-10-27 |
Family
ID=22507398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002103867A RU2238933C2 (en) | 1999-07-16 | 2000-07-11 | Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
Country Status (18)
Country | Link |
---|---|
US (1) | US6555710B1 (en) |
EP (1) | EP1202957B1 (en) |
JP (1) | JP2003505360A (en) |
KR (1) | KR20020013960A (en) |
CN (1) | CN1174956C (en) |
AT (1) | ATE277889T1 (en) |
AU (1) | AU768816B2 (en) |
CA (1) | CA2379319A1 (en) |
CZ (1) | CZ2002158A3 (en) |
DE (1) | DE60014393T2 (en) |
DK (1) | DK1202957T3 (en) |
ES (1) | ES2228557T3 (en) |
HK (1) | HK1048465B (en) |
HU (1) | HUP0201909A3 (en) |
PL (1) | PL353639A1 (en) |
PT (1) | PT1202957E (en) |
RU (1) | RU2238933C2 (en) |
WO (1) | WO2001005745A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
US6087350A (en) * | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
EP1064000B1 (en) * | 1998-03-27 | 2011-07-06 | Oregon Health & Science University | Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders |
KR20030001551A (en) | 2000-05-22 | 2003-01-06 | 레오 파마 에이/에스 | Benzophenones as inhibitors of IL-1β and TNF-α |
WO2002006218A2 (en) * | 2000-07-18 | 2002-01-24 | Bone Care International, Inc. | STABILIZED 1α-HYDROXY VITAMIN D |
HUP0401644A3 (en) | 2001-08-28 | 2008-03-28 | Leo Pharma As | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof |
EA008072B1 (en) * | 2001-12-03 | 2007-02-27 | Новацея, Инк. | Pharmaceutical compositions comprising active vitamin d compounds |
US20030225089A1 (en) * | 2002-04-10 | 2003-12-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
EP1534282B1 (en) | 2002-07-09 | 2006-12-27 | Boehringer Ingelheim Pharma GmbH & Co.KG | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20050020546A1 (en) * | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
MXPA06000708A (en) | 2003-07-24 | 2006-04-19 | Leo Pharma As | Novel aminobenzophenone compounds. |
US20060003950A1 (en) * | 2004-06-30 | 2006-01-05 | Bone Care International, Inc. | Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
RU2394818C2 (en) | 2004-12-13 | 2010-07-20 | Лео Фарма А/С | Triazole-substituted aminobenzophenone compounds |
PE20060777A1 (en) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
EP2266557B1 (en) * | 2008-04-22 | 2013-08-14 | Toyama Chemical Co., Ltd. | Combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
EP2206534A1 (en) | 2008-10-09 | 2010-07-14 | c-a-i-r biosciences GmbH | Dibenzocycloheptanone derivatives und pharmaceutical agents containing these compounds |
HUE029018T2 (en) | 2011-10-12 | 2017-02-28 | Novartis Ag | Method for making uv-absorbing ophthalmic lenses by coating |
WO2014095690A1 (en) | 2012-12-17 | 2014-06-26 | Novartis Ag | Method for making improved uv-absorbing ophthalmic lenses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
-
2000
- 2000-07-11 US US10/031,071 patent/US6555710B1/en not_active Expired - Fee Related
- 2000-07-11 RU RU2002103867A patent/RU2238933C2/en not_active IP Right Cessation
- 2000-07-11 AU AU58071/00A patent/AU768816B2/en not_active Ceased
- 2000-07-11 PT PT00943702T patent/PT1202957E/en unknown
- 2000-07-11 AT AT00943702T patent/ATE277889T1/en not_active IP Right Cessation
- 2000-07-11 CZ CZ2002158A patent/CZ2002158A3/en unknown
- 2000-07-11 CA CA002379319A patent/CA2379319A1/en not_active Abandoned
- 2000-07-11 WO PCT/DK2000/000388 patent/WO2001005745A1/en active IP Right Grant
- 2000-07-11 HU HU0201909A patent/HUP0201909A3/en unknown
- 2000-07-11 JP JP2001511406A patent/JP2003505360A/en active Pending
- 2000-07-11 PL PL00353639A patent/PL353639A1/en not_active Application Discontinuation
- 2000-07-11 CN CNB008115036A patent/CN1174956C/en not_active Expired - Fee Related
- 2000-07-11 DE DE60014393T patent/DE60014393T2/en not_active Expired - Fee Related
- 2000-07-11 EP EP00943702A patent/EP1202957B1/en not_active Expired - Lifetime
- 2000-07-11 DK DK00943702T patent/DK1202957T3/en active
- 2000-07-11 KR KR1020027000614A patent/KR20020013960A/en not_active Application Discontinuation
- 2000-07-11 ES ES00943702T patent/ES2228557T3/en not_active Expired - Lifetime
-
2003
- 2003-01-23 HK HK03100589.4A patent/HK1048465B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002103867A (en) | Aminobenzophenones as inhibitors of IL-1 β and TNF-α | |
RU2335493C2 (en) | Quinoline derivatives as phosphodiesterase inhibitors | |
RU2238933C2 (en) | Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha | |
EP2116244B1 (en) | Method of treating atherosclerosis, dyslipidemias and related conditions | |
US20080161321A1 (en) | Use of Renin Inhibitors in Therapy | |
RU2000129672A (en) | Quinoline derivatives | |
JP2004518723A5 (en) | ||
JP2005536475A5 (en) | ||
RU2002103876A (en) | AMINOBENZOPHENONES AS INTERLEUKIN IL-1β INHIBITORS AND TUMOR NECROSIS FACTOR TNF-α | |
JP2002534468A (en) | ω-Carboxyaryl-substituted diphenylureas as p38 kinase inhibitors | |
RU2001104342A (en) | Quinoline derivatives | |
JP2004517813A5 (en) | ||
CA2344290A1 (en) | Quinazoline derivatives | |
RU2002131886A (en) | AZABICYCLIC CARBAMATES AND THEIR APPLICATION AS ALPHA-7 AGONISTS OF THE NICOTINE ACETYLCHOLINE RECEPTOR | |
CN1268610C (en) | Sulfonamide derivatives | |
CA2539738A1 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
EP3823628A1 (en) | <smallcaps/>? ? ?s? ? ? ? ?certain (2)- <ns1:i>n</ns1:i>?-[(1 <ns2:i>s</ns2:i>?)-1-cyano-2-phenylethyl]-1,4- oxazepane-2-carboxamides for treating inflammatory bowel disease | |
RU2002103865A (en) | Aminobenzophenones as inhibitors of IL-1β and TNF-α | |
RU2019128534A (en) | CHEMICAL COMPOUNDS FOR TUBERCULOSIS TREATMENT | |
RU2003128985A (en) | CARBAMATE DERIVATIVES FOR USE TO PREVENT OR TREAT MOVEMENT DISORDERS | |
RU2012114718A (en) | Pyridine compounds of a condensed ring as subtype selective modulators of receptors of sphingosine-1-phosphate-2 (S1P2) | |
JP2008524145A5 (en) | ||
RU2002110328A (en) | Substituted benzimidazole preparation | |
CA2581232A1 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i | |
RU96123227A (en) | AMIDIC DERIVATIVES AND THEIR THERAPEUTIC USE |